Oral Presentation Speaker Resources

Oral Presentation Speakers

The AMRPA Education Committee has completed reviews for abstract submissions for both oral and poster presentations. Thank you to all that submitted! Letters of your submission status has been sent out. 

Complete Your Disclosure Form

All speakers must complete their online disclosure form to be included in the program.

Important Deadlines

Headshots, biographies, CVs and disclosures are due June 15, 2026. Please send your headshot, biography, and CV to [email protected] and complete your disclosure form at the link above.

PowerPoint Presentation

We ask that you use the AMRPA slide template to create your PowerPoint presentation. Please email a copy of ‎your presentation in PDF and PowerPoint format (10 MB maximum file size) to AMRPA staff at [email protected] by August 15th.

Register for the Conference

All speakers must register and pay to attend and participate in the conference. Speakers are eligible for a $50 discounted registration rate.

 

  1. If you are registering as an individual, first indicate Member or Non-member and then select “Speaker Registration”. Follow all prompts and select pre-conference add-ons as needed. 
  2. If you are utilizing the Group Registration option, the system allows you to register speakers and non-speakers as needed. Group registrations with 5 attendees or more will receive the $45 group discount (in addition to the speaker discount where applicable).

ACCME Requirements

Please read the following pertinent ACCME requirements regarding your presentation:

Information for Learners. Information on needs, expected results, and purpose or objectives will be provided to learners by AMRPA. These will be framed in terms of physician change or health status improvement which is in keeping with our CME mission.

Content Validation. AMRPA expects that all of its CME activities will adhere to the ACCME’s content validation value statements. Specifically, all the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. Please contact AMRPA if you do not feel your presentation can meet these standards.

Safeguards against Commercial Bias. AMRPA expects that the content or format of CME activities and related materials will promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. We employ several strategies to ensure the absence of commercial bias and you are integral to their successful implementation.

  • We will be disclosing to our learners before the activity whether  or not you have relevant financial relationships. If, on  the basis of the information you provide, we determine that you have relevant financial relationships with commercial interests that create a conflict of interest with respect to your role in this activity, together we will determine and document a strategy or strategies to resolve that conflict of interest.
  • We also remind you that CME must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If your CME educational material or content includes trade names, trade names from several companies should be used where available, not just trade names from a single company.

Measurements of Effectiveness. AMRPA will be seeking feedback from the learners on the effectiveness of this CME activity through evaluations. We will be seeking information on what changes the learners will make as a result of the presentations (oral and posters).

Educational Materials. Educational materials that are a part of this activity, such as slides and published abstracts cannot contain any advertising, trade names, or product-group messages.

Questions? 

Please contact AMRPA Headquarters

Scroll to Top
Skip to content